Literature DB >> 21240493

Pilot study: possible association of IL10 promoter polymorphisms with CRMO.

J Hamel, D Paul, M Gahr, C M Hedrich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21240493     DOI: 10.1007/s00296-010-1768-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  16 in total

1.  Chronic recurrent multifocal osteomyelitis in children.

Authors:  C Schultz; P M Holterhus; A Seidel; S Jonas; M Barthel; K Kruse; P Bucsky
Journal:  Pediatr Infect Dis J       Date:  1999-11       Impact factor: 2.129

2.  Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus.

Authors:  A W Gibson; J C Edberg; J Wu; R G Westendorp; T W Huizinga; R P Kimberly
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

3.  Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases.

Authors:  C Job-Deslandre; S Krebs; A Kahan
Journal:  Joint Bone Spine       Date:  2001-05       Impact factor: 4.929

4.  Hereditary periodic fever syndromes.

Authors:  Daniel L Kastner
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

5.  Extended IL10 haplotypes and their association with HIV progression to AIDS.

Authors:  T K Oleksyk; S Shrestha; A L Truelove; J J Goedert; S M Donfield; J Phair; S Mehta; S J O'Brien; M W Smith
Journal:  Genes Immun       Date:  2009-03-19       Impact factor: 2.676

6.  Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up.

Authors:  Adam M Huber; Pei-Yoong Lam; Catherine M Duffy; Rae S M Yeung; Michael Ditchfield; Dara Laxer; William G Cole; H Kerr Graham; Roger C Allen; Ronald M Laxer
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

7.  Chronic recurrent multifocal osteomyelitis: a noninfectious inflammatory process.

Authors:  S M King; R M Laxer; D Manson; R Gold
Journal:  Pediatr Infect Dis J       Date:  1987-10       Impact factor: 2.129

Review 8.  Chronic recurrent multifocal osteomyelitis and psoriasis--a report of a new association and review of related disorders.

Authors:  R M Laxer; A D Shore; D Manson; S King; E D Silverman; D M Wilmot
Journal:  Semin Arthritis Rheum       Date:  1988-05       Impact factor: 5.532

9.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.

Authors:  Andre Franke; Tobias Balschun; Tom H Karlsen; Jurgita Sventoraityte; Susanna Nikolaus; Gabriele Mayr; Francisco S Domingues; Mario Albrecht; Michael Nothnagel; David Ellinghaus; Christian Sina; Clive M Onnie; Rinse K Weersma; Pieter C F Stokkers; Cisca Wijmenga; Maria Gazouli; David Strachan; Wendy L McArdle; Séverine Vermeire; Paul Rutgeerts; Philip Rosenstiel; Michael Krawczak; Morten H Vatn; Christopher G Mathew; Stefan Schreiber
Journal:  Nat Genet       Date:  2008-10-05       Impact factor: 38.330

10.  A hallmark of balancing selection is present at the promoter region of interleukin 10.

Authors:  J N Wilson; K Rockett; B Keating; M Jallow; M Pinder; F Sisay-Joof; M Newport; D Kwiatkowski
Journal:  Genes Immun       Date:  2006-08-31       Impact factor: 2.676

View more
  14 in total

Review 1.  An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.

Authors:  Andrea Taddio; Floriana Zennaro; Serena Pastore; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

2.  Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO).

Authors:  Sigrun Renate Hofmann; Anne Sophie Kubasch; Ursula Range; Martin Walther Laass; Henner Morbach; Hermann Joseph Girschick; Christian Michael Hedrich
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

Review 3.  Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis.

Authors:  Polly J Ferguson; Monica Sandu
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

4.  Chronic nonbacterial osteomyelitis in a child with previous juvenile dermatomyositis.

Authors:  Daniela S Ardelean; Peter B Dent; Polly J Ferguson; Ronald M Laxer
Journal:  J Rheumatol       Date:  2013-03       Impact factor: 4.666

Review 5.  Chronic recurrent multifocal osteomyelitis.

Authors:  Patrícia Costa-Reis; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2013-05-22       Impact factor: 8.317

6.  Update: Cytokine Dysregulation in Chronic Nonbacterial Osteomyelitis (CNO).

Authors:  Sigrun R Hofmann; Angela Roesen-Wolff; Gabriele Hahn; Christian M Hedrich
Journal:  Int J Rheumatol       Date:  2012-05-21

7.  Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO).

Authors:  Christian M Hedrich; Sigrun R Hofmann; Jessica Pablik; Henner Morbach; Hermann J Girschick
Journal:  Pediatr Rheumatol Online J       Date:  2013-12-23       Impact factor: 3.054

8.  Serum Interleukin-6 and CCL11/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis.

Authors:  Sigrun Ruth Hofmann; Fanny Böttger; Ursula Range; Christian Lück; Henner Morbach; Hermann Joseph Girschick; Meinolf Suttorp; Christian Michael Hedrich
Journal:  Front Pediatr       Date:  2017-12-01       Impact factor: 3.418

Review 9.  Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment.

Authors:  Sigrun R Hofmann; Franz Kapplusch; Hermann J Girschick; Henner Morbach; Jessica Pablik; Polly J Ferguson; Christian M Hedrich
Journal:  Curr Osteoporos Rep       Date:  2017-12       Impact factor: 5.096

Review 10.  Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach.

Authors:  Andrea Taddio; Giovanna Ferrara; Antonella Insalaco; Manuela Pardeo; Massimo Gregori; Martina Finetti; Serena Pastore; Alberto Tommasini; Alessandro Ventura; Marco Gattorno
Journal:  Pediatr Rheumatol Online J       Date:  2017-12-29       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.